Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07229482 · ClinicalTrials.gov registry record · NA

Potatoes, Type 2 Diabetes, and Cardiometabolic Health

A NA study, sponsored by Virginia Polytechnic Institute and State University.

Not yet
Registry status
NA
Development phase
42
Enrollment target

NCT07229482: Clinical Trial NA study, sponsored by Virginia Polytechnic Institute and State University.

NCT07229482 is a NA study that has not yet begun recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07229482, a NA study, has not yet begun recruiting, sponsored by Virginia Polytechnic Institute and State University.

NOT YET RECRUITING
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

Type 2 diabetes (T2D) is a major chronic health condition which increases risk of coronary artery disease, frailty, cognitive decline, and mortality. Additionally, hypertension is a major comorbidity for individuals with T2D, further increasing the risk of adverse cardiovascular outcomes. The prevalence of both conditions increases with advancing age. There is an urgent need to identify new approaches to prevent the development of T2D and improve cardiometabolic health in older adults 50-70 years of age. Whole white potatoes are an unprocessed food rich in essential nutrients often under-consumed by Americans, including potassium, fiber, magnesium, vitamins C and B6, and phytochemicals. Each of these nutrients individually are associated with cardiometabolic health benefits. Potatoes account for a significant amount of the intake of these nutrients in the US diet and are well-positioned to be a foundational element of a healthy dietary pattern. However, there are few interventional studies evaluating the effect of potatoes on cardiometabolic health, and the evidence from observational studies is mixed, leaving a significant gap in knowledge regarding the potential for potatoes to be included in healthy dietary patterns. The results of our proposed study will provide foundational data that inform future dietary guidelines regarding the inclusion of white potatoes as part of a healthy US dietary pattern.

Primary Outcome

Glucose tolerance will be assessed using a 2-hour oral glucose tolerance test (OGTT, 75 g glucose load). Blood will be collected at baseline (fasting) and thereafter at 30-minute intervals (5 total measurements in 2 hours).

Interventions

  • OTHER Controlled diet: Potato-rich healthy dietary pattern
  • OTHER Controlled diet: Typical Western-style dietary pattern

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2026-06
Est. Completion 2029-03
Phase NA

What is known before NCT07229482 opens enrollment

NCT07229482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Controlled diet: Potato-rich healthy dietary pattern is the first listed.

NCT07229482 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07229482 about?

NCT07229482 is a clinical study titled "Potatoes, Type 2 Diabetes, and Cardiometabolic Health". Type 2 diabetes (T2D) is a major chronic health condition which increases risk of coronary artery disease, frailty, cognitive decline, and mortality. Additionally, hypertension is a major comorbidity for individuals with T2D, further increasing the risk of adverse cardiovascular outcomes. The preval...

What is the current status of trial NCT07229482?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2026-06. Estimated completion is 2029-03.

What interventions are being tested in trial NCT07229482?

The interventions under investigation include: Controlled diet: Potato-rich healthy dietary pattern (OTHER), Controlled diet: Typical Western-style dietary pattern (OTHER).

Who is sponsoring clinical trial NCT07229482?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07229482's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07229482, the US trial registry maintained by the National Library of Medicine. NCT07229482 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.